Co-immunization with M-CSFR and mM-CSF DNA vaccines is better than M-CSFR-mM-CSF fusion DNA vaccine

Haematologica

Volumn 87, Issue 10, 2002, Pages 1087-1094

  Wang, Min Hui ^a   Zheng, Guo Guang ^a   Wu, Ke Fu ^a   Li, Ge ^a   Lin, Yong Min ^a   Rao, Qing ^a   Song, Yu Hua ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Co immunization; DNA vaccine; Fusion DNA vaccine; Macrophage colony stimulating factor receptor; Membrane bound macrophage colony stimulating factor

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR DNA VACCINE; MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR MEMBRANE BOUND MACROPHAGE COLONY STIMULATING FACTOR FUSION DNA VACCINE; MEMBRANE BOUND MACROPHAGE COLONY STIMULATING FACTOR; MEMBRANE BOUND MACROPHAGE COLONY STIMULATING FACTOR DNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; SPLEEN CELL; VACCINATION;

ANIMALS; BLOTTING, WESTERN; CANCER VACCINES; CELL MEMBRANE; COS CELLS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; PLASMIDS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0036799251     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247:1465-8.
2. Shedlock DJ, Weiner DB. DNA vaccination: Antigen presentation and the induction of immunity. J Leukoc Biol 2000; 68:793-806.
3. Mendiratta SK, Thai G, Eslahi NK, Thull NM, Matar M, Bronte V, et al. Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. Cancer Res 2001; 61:859-63.
4. Walsh P, Gonzalez R, Dow S, Elmslie R, Potter T, Glode LM, et al. A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial. Hum Gene Ther 2000; 11:1355-68.
5. Daemen T, Pries F, Bungener L, Kraak M, Regts J, Wilschut J. Genetic immunization against cervical carcinoma: Induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7. Gene Ther 2000; 7:1859-66.
6. Hung CF, Hsu KF, Cheng WF, Chai CY, He L, Ling M, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res 2001; 61:1080-8.
7. Scholl SM, Balloul JM, Le Goc G, Bizouarne N, Schatz C, Kieny MP, et al. Recombinant vacc[nia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer. J Immunother 2000; 23:570-80.
8. Cerretti DP, Wignall J, Anderson D, Tushinski RJ, Gallis BM, Stya M, et al. Human macrophage colony-stimulating factor: Alternative RNA and protein processing from a single gene. Mol Immunol 1988; 25:761-70.
9. Kimura F, Suzu S, Nakamura Y, Wakimoto N, Kanatani Y, Yanai N, et al. Structural analysis of proteoglycan macrophage colony-stimulating factor. J Biol Chem 1994; 26:19751-6.
10. Janowska-Wieczorek A, Belch AR, Jacobs A, Bowen D, Padua RA, Paietta E, et al. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood 1991; 77:1796-803.
11. Burthem J, Baker PK, Hunt JA, Cawley JC. The function of c-fms in hairy-cell leukemia: Macrophage colony-stimulating factor stimulates hairy-cell movement. Blood 1994; 83:1381-9.
12. McGlynn H, Baker AH, Padua RA. Biological consequences of a point mutation at codon 969 of the FMS gene. Leuk Res 1998; 22:365-72.
13. Maher MG, Sapi E, Turner B, Gumbs A, Perrotta PL, Carter D, et al. Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence. Clin Cancer Res 1998; 4:1851-6.
14. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Expression of the macrophage colonystimulating factor and its receptor in gynecologic malignancies. Cancer 1991; 67:990-6.
15. Wu KF, Rao Q, Zheng GG, Geng YQ, Li M, Kong J, et al. Enhancement of J6-1 human leukemic cell proliferation by cell-cell contact: Role of an M-CSF-like membrane-associated growth factor MAF-J6-1. Leuk Res 1994; 18:843-9.
16. Wu KF, Rao Q, Zheng GG, He ZH, Ying HG, Song YH, et al. Enhancement of J6-1 human leukemic cell proliferation by membrane-bound M-CSF through a cell-cell contact mechanism II. Role of an M-CSF receptor-like membrane protein. Leuk Res 1998; 22:55-60.
17. Rao Q, Han JS, Geng YQ. Antigen association of J6-1 cell membrane associated factor receptor with macrophage colony stimulating factor. Chin J Cancer Res 1999; 11:235-40.
18. Zheng GG, Wu KF, Geng YQ, Kong J, Al-Katib A, Dan M, et al. Expression of membrane-associated macrophage colony-stimulating factor (M-CSF) in Hodgkin's disease and other hematologic malignancies. Leuk Lymphoma 1999; 32:339-44.
19. Wu KF, He ZH, Zheng GG, Rao Q, Wang X. Receptor role of membrane bound macrophage colony-stimulating factor. Chinese Sci Bull 1998; 43:1034-7.
20. Wu KF, Zheng GG, Rao Q, Geng YQ, Yang WQ, Song YH. Cellular macrophage colony-stimulating factor and its role. Haematologica 1999; 84:951-2.
21. Zheng GG, Rao Q, Wu KF, He ZH, Geng YQ. Membranebound macrophage colony stimulating factor and its receptor play adhesion molecule-like role in leukemic cells. Leuk Res 2000; 24:375-83.
22. Li G, Song YH, Wu KF, Lin YM, Cao ZY, Zheng GG. Clone and expression of mutant M-CSF and its receptor from human leukemic cell line J6-1. Leuk Res 2002; 26:377-82.
23. Wang Y, Zheng GG, Wu KF, Li G, Rao Q. Construction of macrophage colony-stimulating factor receptor DNA vaccine. Haematologica 2001; 86:1219-20.
24. Restifo NP, Ying H, Hwang L, Leitner WW. The promise of nucleic acid vaccines. Gene Ther 2000; 7:89-92.
25. Haupt K, Roggendorf M, Mann K. The potential of DNA vaccination against tumor-associated antigens for antitumor therapy. Exp Biol Med 2002; 227:227-37.
26. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193:727-40.
27. Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML. Over expression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: A poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 1997; 3:999-1007.
28. Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol Oncol 2000; 77:405-9.
29. Toy EP, Chambers JT, Kacinski BM, Flick MB, Chambers SK. The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001; 80:194-200.
30. Yang WQ, Wu KF, Zhao MH, Zhang LS, Song NG, Song YH. Co-expression of M-CSF with its receptor in human hepatoma cells and its potential roles. Chin J Cancer Res 1999; 11:79-84.
31. Song YH, Lin YM, Wu KF, Yang WQ, Li G, Zheng DX. Immunohistochemical observation of macrophage colony stimulating factor and its receptor in breast cancer and hepatoma tissues. Chin J Cancer Res 2001; 13:1-4.
32. Tanaka M, Kaneda Y, Fujii S, Yamano T, Hashimoto K, Huang SK, et al. Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma. Mol Ther 2002; 5:291-9.
33. + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J Immunol 2002; 168:562-8.
34. Sun X, Hodge LM, Jones HP, Tabor L, Simecka JW. Coexpression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination. Vaccine 2002; 20:1466-74.